Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Immunol. 2007 Aug;7(8):650-4.

What does the future hold for cell-based tolerogenic therapy?

Author information

  • 1Immune Tolerance Network and of the Diabetes Center at the University of California, USA.

Abstract

Evidence from animal models has shown that the transfer of regulatory T cells or tolerogenic dendritic cells can prevent or cure transplant rejection or re-establish self-tolerance in autoimmune disease. The potential of these tolerogenic cells for the treatment of T-cell-mediated diseases in humans has gained momentum in recent years. Here, Nature Reviews Immunology asks four leading researchers to provide their view on the future of cell-based tolerogenic therapy and to highlight some important issues that must be considered before this form of immunotherapy can become a reality.

PMID:
17653127
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk